Ritonavir
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Ritonavir and local guidelines before prescribing.
Mechanism
Protease inhibitor and potent CYP3A4 booster.
Uses
HIV infection (boosting agent), COVID-19 (with nirmatrelvir).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, diarrhoea, taste disturbance, hepatotoxicity, hyperlipidaemia.
Interactions
Very many: statins, anticoagulants, opioids, steroids, antiarrhythmics, antipsychotics; reduces levels of oestrogen.
Contraindications and cautions
Severe liver impairment
Monitoring
LFT, lipids, glucose
Pregnancy and breastfeeding
Used in pregnancy where indicated
Renal and hepatic impairment
Avoid in severe liver impairment
Overdose and reversal
Supportive
Special advice
Always check interaction database before prescribing or stopping.
More from the textbook: uses, cautions and other points
- High-risk people in the community: Antivirals (e.g. nirmatrelvir with ritonavir - check interactions) per NICE.
Respiratory: Infections - Interactions - CYP3A4 inhibitors (ritonavir and cobicistat, itraconazole, clarithromycin) block breakdown of inhaled or nasal fluticasone and budesonide → Cushing's syndrome and adrenal suppression; enzyme inducers (rifampicin, carbamazepine, phenytoin) reduce steroid effect - double replacement doses may be needed.
Endocrine: Anatomy Physiology and Pharmacology - Nirmatrelvir–ritonavir (Paxlovid) - oral, within 5 days of symptoms; ritonavir is a strong CYP3A4 inhibitor - major interactions with statins, DOACs, amiodarone, tacrolimus and ciclosporin, some antiseizure drugs, sildenafil, salmeterol, many others - always check (e.g. the Liverpool COVID-19 interaction checker).
ID: How Infection Happens - Nirmatrelvir–ritonavir | COVID-19 in high-risk people; major CYP3A4 interactions.
ID: How Infection Happens - Nirmatrelvir–ritonavir has major interactions - always check.
ID: How Infection Happens - Cushingoid features in a patient on ritonavir and inhaled fluticasone | CYP3A4 inhibition - iatrogenic Cushing's and adrenal suppression
Endocrine: Anatomy Physiology and Pharmacology - Any steroid combined with a CYP3A4 inhibitor (e.g. ritonavir, cobicistat, itraconazole, clarithromycin). These block steroid breakdown - even inhaled fluticasone or injected triamcinolone can then cause Cushing's syndrome and adrenal suppression.
Endocrinology: Adrenal Disease - Exogenous (commonest overall) | Prescribed glucocorticoids - oral, inhaled, topical, injected; steroid plus CYP3A4 inhibitor (e.g. ritonavir)
Endocrinology: Adrenal Disease
Where it is discussed in the book
- Respiratory: Infections (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Adrenal Disease (3 mentions)
- Gynaecology: Fertility Contraception Menopause (1 mention)
- ID: How Infection Happens (3 mentions)
- ID: HIV, viral hepatitis and blood-borne viruses (3 mentions)
- ID: Viral, fungal and parasitic infections (2 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (3 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Integrated respiratory chapter (1 mention)
- Biochemistry: Enzymes, vitamins and trace elements (1 mention)
- Microbiology: Virology - structure, replication and important viral infections (4 mentions)